Abstract
Many drug delivery systems have indicated improvement in delivery of various drug molecules and among these biodegradable and biocompatible polymers such as poly(D,L-lactide-co-glycolide) (PLGA) have been shown to enhance intracellular uptake of drug candidates when formulated as nanoparticles. PLGA nanoparticles were prepared by means of a double emulsion solvent evaporation technique and evaluated in terms of size, encapsulation efficiency, surface charge, isoniazid release and in vitro transport. The nanoparticles have an average size of 237 nm and were previously shown to be distributed in several tissues after oral administration without triggering an immune response. This study focussed on the in vitro permeation of the PLGA nanoparticles across different membranes and showed that although Rhodamine 6G-labelled nanoparticles are efficiently delivered across the intestinal epithelium, its epithelial permeability changes when a drug such as isoniazid is encapsulated. Future studies should focus on ways to optimise PLGA nanoparticle delivery when a drug such as isoniazid is encapsulated for instance by coating with polymers such as polyethylene glycol.
Keywords: Caco-2, isoniazid, nanoparticles, parallel artificial membrane permeability assay, poly(D, L-lactide-co-glycolide), transport
Current Drug Delivery
Title:Permeation of PLGA Nanoparticles Across Different in vitro Models
Volume: 9 Issue: 6
Author(s): Lindiwe A. Nkabinde, Lungile N.N. Shoba-Zikhali, Boitumelo Semete-Makokotlela, Lonji Kalombo, Hulda S. Swai, Rose Hayeshi, Brendon Naicker, Thembela K. Hillie and Josias H. Hamman
Affiliation:
Keywords: Caco-2, isoniazid, nanoparticles, parallel artificial membrane permeability assay, poly(D, L-lactide-co-glycolide), transport
Abstract: Many drug delivery systems have indicated improvement in delivery of various drug molecules and among these biodegradable and biocompatible polymers such as poly(D,L-lactide-co-glycolide) (PLGA) have been shown to enhance intracellular uptake of drug candidates when formulated as nanoparticles. PLGA nanoparticles were prepared by means of a double emulsion solvent evaporation technique and evaluated in terms of size, encapsulation efficiency, surface charge, isoniazid release and in vitro transport. The nanoparticles have an average size of 237 nm and were previously shown to be distributed in several tissues after oral administration without triggering an immune response. This study focussed on the in vitro permeation of the PLGA nanoparticles across different membranes and showed that although Rhodamine 6G-labelled nanoparticles are efficiently delivered across the intestinal epithelium, its epithelial permeability changes when a drug such as isoniazid is encapsulated. Future studies should focus on ways to optimise PLGA nanoparticle delivery when a drug such as isoniazid is encapsulated for instance by coating with polymers such as polyethylene glycol.
Export Options
About this article
Cite this article as:
A. Nkabinde Lindiwe, N.N. Shoba-Zikhali Lungile, Semete-Makokotlela Boitumelo, Kalombo Lonji, S. Swai Hulda, Hayeshi Rose, Naicker Brendon, K. Hillie Thembela and H. Hamman Josias, Permeation of PLGA Nanoparticles Across Different in vitro Models, Current Drug Delivery 2012; 9 (6) . https://dx.doi.org/10.2174/156720112803529819
DOI https://dx.doi.org/10.2174/156720112803529819 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers